Cutter GR - Search Results

1

Responsiveness and predictive values in PPMS: an uncertain message.

Cutter GR, Lublin FD. Cutter GR, et al. Neurology. 2008 Mar 25;70(13 Pt 2):1061-2. doi: 10.1212/01.wnl.0000306414.53844.50. Neurology. 2008. PMID: 18362265 No abstract available.

2

Clinical outcomes assessment in multiple sclerosis.

Rudick R, Antel J, Confavreux C, Cutter G, Ellison G, Fischer J, Lublin F, Miller A, Petkau J, Rao S, Reingold S, Syndulko K, Thompson A, Wallenberg J, Weinshenker B, Willoughby E. Rudick R, et al. Ann Neurol. 1996 Sep;40(3):469-79. doi: 10.1002/ana.410400321. Ann Neurol. 1996. PMID: 8797541 Review.

3

Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force.

Rudick R, Antel J, Confavreux C, Cutter G, Ellison G, Fischer J, Lublin F, Miller A, Petkau J, Rao S, Reingold S, Syndulko K, Thompson A, Wallenberg J, Weinshenker B, Willoughby E. Rudick R, et al. Ann Neurol. 1997 Sep;42(3):379-82. doi: 10.1002/ana.410420318. Ann Neurol. 1997. PMID: 9307263

4

Development of a multiple sclerosis functional composite as a clinical trial outcome measure.

Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, Syndulko K, Weinshenker BG, Antel JP, Confavreux C, Ellison GW, Lublin F, Miller AE, Rao SM, Reingold S, Thompson A, Willoughby E. Cutter GR, et al. Brain. 1999 May;122 ( Pt 5):871-82. doi: 10.1093/brain/122.5.871. Brain. 1999. PMID: 10355672

5

Effect of relapses on development of residual deficit in multiple sclerosis.

Lublin FD, Baier M, Cutter G. Lublin FD, et al. Neurology. 2003 Dec 9;61(11):1528-32. doi: 10.1212/01.wnl.0000096175.39831.21. Neurology. 2003. PMID: 14663037

6

The MS Co-Operative REsearch (MS-CORE) group: an alternate approach to fostering multicenter studies.

Cohen J, Cutter G, Lublin F, Schwid S. Cohen J, et al. Mult Scler. 2004 Jun;10(3):332-3. doi: 10.1191/1352458504ms1018xx. Mult Scler. 2004. PMID: 15222702 No abstract available.

7

Clinical characteristics of progressive relapsing multiple sclerosis.

Tullman MJ, Oshinsky RJ, Lublin FD, Cutter GR. Tullman MJ, et al. Among authors: cutter gr. Mult Scler. 2004 Aug;10(4):451-4. doi: 10.1191/1352458504ms1059oa. Mult Scler. 2004. PMID: 15327045

8

Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis.

Frohman EM, Havrdova E, Lublin F, Barkhof F, Achiron A, Sharief MK, Stuve O, Racke MK, Steinman L, Weiner H, Olek M, Zivadinov R, Corboy J, Raine C, Cutter G, Richert J, Filippi M. Frohman EM, et al. Arch Neurol. 2006 Apr;63(4):614-9. doi: 10.1001/archneur.63.4.614. Arch Neurol. 2006. PMID: 16606781 No abstract available.

9

Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment.

Polman CH, Reingold SC, Barkhof F, Calabresi PA, Clanet M, Cohen JA, Cutter GR, Freedman MS, Kappos L, Lublin FD, McFarland HF, Metz LM, Miller AE, Montalban X, O'Connor PW, Panitch H, Richert JR, Petkau J, Schwid SR, Sormani MP, Thompson AJ, Weinshenker BG, Wolinsky JS. Polman CH, et al. Among authors: cutter gr. Neurology. 2008 Mar 25;70(13 Pt 2):1134-40. doi: 10.1212/01.wnl.0000306410.84794.4d. Neurology. 2008. PMID: 18362273

10

Proof of concept studies for tissue-protective agents in multiple sclerosis.

Mehta LR, Schwid SR, Arnold DL, Cutter GR, Aradhye S, Balcer LJ, Calabresi PA, Cohen JA, Cole PE, Glanzman R, Goelz S, Inglese M, Kapoor R, Kappos L, Kreitman R, Lublin FD, Mann A, Marrie RA, O'Looney P, Polman CH, Ravina BM, Reingold SC, Richert JR, Sandrock AW, Waubant E. Mehta LR, et al. Among authors: cutter gr. Mult Scler. 2009 May;15(5):542-6. doi: 10.1177/1352458508101939. Mult Scler. 2009. PMID: 19389749 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

712 results

Search Page